Perspectives on Europe and the US, written for China-based teams.
Regulatory updates, practical guides and points of view from the Kaiveo Medical team. Three long-form guides are published; the remaining topics are in preparation.
Browse by topic
Choosing between centralised and decentralised procedures: a decision framework for Chinese sponsors
Mandatory scope settles the question for many products. Where it does not, the choice turns on your market footprint, a single set of product information, and the Reference Member State you pick.
Read articlePreparing for a notified-body audit: what surprises non-EU manufacturers most
A notified body is not certifying your quality system as an end in itself. It is deciding whether your device may be placed on the European market, and it audits the evidence for that decision.
Read articleNo articles in this category yet.
Discuss your regulatory questions.
Email us about the EU or FDA questions that matter to your programme.
Have a question these articles don’t answer?
Tell us about your product and your ambition. We will come back with an honest view of the pathway, the timeline and the first three steps.
Or start with a market-entry assessment →
We aim to reply within two working days. Language support is agreed for each engagement.
